Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filippo Conti

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Cell Death & Disease|August 20, 2020
MICAL2 is essential for myogenic lineage commitmentNefele Giarratana, Filippo Conti, Rita La Rovere, et al.
Critical Care Medicine|March 14, 2023
Immune Profiling Panel Gene Set Identifies Critically Ill Patients With Low Monocyte Human Leukocyte Antigen-DR Expression: Preliminary Results From the REAnimation Low Immune Status Marker (REALISM) StudyEstelle Peronnet, Sophie Blein, Fabienne Venet, et al.
Journal of Clinical Medicine|January 11, 2022
Concomitant Assessment of Monocyte HLA-DR Expression and Ex Vivo TNF-α Release as Markers of Adverse Outcome after Various Injuries-Insights from the REALISM StudyFrank Bidar, Maxime Bodinier, Fabienne Venet, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 2, 2004
Dual control of neurogenesis by PC3 through cell cycle inhibition and induction of Math1Daniela Canzoniere, Stefano Farioli-Vecchioli, Filippo Conti, et al.
Annals of Intensive Care|March 5, 2022
Recombinant human interleukin-7 reverses T cell exhaustion ex vivo in critically ill COVID-19 patientsFrank Bidar, Sarah Hamada, Morgane Gossez, et al.
Annals of Intensive Care|April 1, 2022
Correction to: Recombinant human interleukin-7 reverses T cell exhaustion ex vivo in critically ill COVID-19 patientsFrank Bidar, Sarah Hamada, Morgane Gossez, et al.
Cell Host & Microbe|September 12, 2014
Screening in planarians identifies MORN2 as a key component in LC3-associated phagocytosis and resistance to bacterial infectionPrasad Abnave, Giovanna Mottola, Gregory Gimenez, et al.
Frontiers in Immunology|November 17, 2022
A 9-mRNA signature measured from whole blood by a prototype PCR panel predicts 28-day mortality upon admission of critically ill COVID-19 patientsClaire Tardiveau, Guillaume Monneret, Anne-Claire Lukaszewicz, et al.
Ebiomedicine|March 29, 2022
T cell response against SARS-CoV-2 persists after one year in patients surviving severe COVID-19Fabienne Venet, Morgane Gossez, Frank Bidar, et al.
Journal for Immunotherapy of Cancer|April 2, 2026
Transforming growth factor β induced as a novel secreted immune checkpoint counterinhibiting human tumor-associated T cellsMaria Manuela Rosado, Eleonora Timperi, Ombretta Melaiu, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Cell Death & Disease|August 20, 2020
MICAL2 is essential for myogenic lineage commitmentNefele Giarratana, Filippo Conti, Rita La Rovere, et al.
Critical Care Medicine|March 14, 2023
Immune Profiling Panel Gene Set Identifies Critically Ill Patients With Low Monocyte Human Leukocyte Antigen-DR Expression: Preliminary Results From the REAnimation Low Immune Status Marker (REALISM) StudyEstelle Peronnet, Sophie Blein, Fabienne Venet, et al.
Journal of Clinical Medicine|January 11, 2022
Concomitant Assessment of Monocyte HLA-DR Expression and Ex Vivo TNF-α Release as Markers of Adverse Outcome after Various Injuries-Insights from the REALISM StudyFrank Bidar, Maxime Bodinier, Fabienne Venet, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 2, 2004
Dual control of neurogenesis by PC3 through cell cycle inhibition and induction of Math1Daniela Canzoniere, Stefano Farioli-Vecchioli, Filippo Conti, et al.
Annals of Intensive Care|March 5, 2022
Recombinant human interleukin-7 reverses T cell exhaustion ex vivo in critically ill COVID-19 patientsFrank Bidar, Sarah Hamada, Morgane Gossez, et al.
Annals of Intensive Care|April 1, 2022
Correction to: Recombinant human interleukin-7 reverses T cell exhaustion ex vivo in critically ill COVID-19 patientsFrank Bidar, Sarah Hamada, Morgane Gossez, et al.
Cell Host & Microbe|September 12, 2014
Screening in planarians identifies MORN2 as a key component in LC3-associated phagocytosis and resistance to bacterial infectionPrasad Abnave, Giovanna Mottola, Gregory Gimenez, et al.
Frontiers in Immunology|November 17, 2022
A 9-mRNA signature measured from whole blood by a prototype PCR panel predicts 28-day mortality upon admission of critically ill COVID-19 patientsClaire Tardiveau, Guillaume Monneret, Anne-Claire Lukaszewicz, et al.
Ebiomedicine|March 29, 2022
T cell response against SARS-CoV-2 persists after one year in patients surviving severe COVID-19Fabienne Venet, Morgane Gossez, Frank Bidar, et al.
Journal for Immunotherapy of Cancer|April 2, 2026
Transforming growth factor β induced as a novel secreted immune checkpoint counterinhibiting human tumor-associated T cellsMaria Manuela Rosado, Eleonora Timperi, Ombretta Melaiu, et al.
Pageof 4